Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells

Gastroenterology

Volumn 143, Issue 3, 2012, Pages

  Buurman, Reena ^a   Grlevik, Engin ^a   Schffer, Vera ^a   Eilers, Marlies ^a   Sandbothe, Maria ^a   Kreipe, Hans ^a   Wilkens, Ludwig ^a   Schlegelberger, Brigitte ^a   Khnel, Florian ^a   Skawran, Britta ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

HGF; Liver Cancer; Mouse Model; RNA Processing

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 449; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC TRANSFECTION; HISTONE ACETYLATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION;

EID: 84865479772     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.05.033     Document Type: Article

References (52)

1. M. Colombo Treatment of hepatocellular carcinoma J Viral Hepat 4 Suppl 1 1997 125 130
2. C. Herold, T. Reck, P. Fischler Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre Liver 22 2002 23 28 (Pubitemid 34552521)
3. F. Mitelman, B. Johansson, F. Mertens Catalog of chromosome aberrations in cancer 1994 Wiley-Liss New York
4. K. Okuda Hepatocellular carcinoma J Hepatol 32 2000 225 237 (Pubitemid 30123637)
5. K.N. Bhalla Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies J Clin Oncol 23 2005 3971 3993 (Pubitemid 46218700)
6. P. Marks, R.A. Rifkind, V.M. Richon Histone deacetylases and cancer: causes and therapies Nat Rev Cancer 1 2001 194 202 (Pubitemid 33741894)
7. S. Ropero, M. Esteller The role of histone deacetylases (HDACs) in human cancer Mol Oncol 1 2007 19 25 (Pubitemid 46776612)
8. R. Schneider-Stock, M. Ocker Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors IDrugs 10 2007 557 561 (Pubitemid 47186508)
9. M.F. Fraga, E. Ballestar, A. Villar-Garea Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer Nat Genet 37 2005 391 400
10. N. Kourmouli, P. Jeppesen, S. Mahadevhaiah Heterochromatin and tri-methylated lysine 20 of histone H4 in animals J Cell Sci 117 2004 2491 2501 (Pubitemid 38877845)
11. S. Minucci, P.G. Pelicci Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat Rev Cancer 6 2006 38 51 (Pubitemid 43054973)
12. O. Witt, H.E. Deubzer, T. Milde HDAC family: what are the cancer relevant targets? Cancer Lett 277 2009 8 21
13. C.B. Yoo, P.A. Jones Epigenetic therapy of cancer: past, present and future Nat Rev Drug Discov 5 2006 37 50
14. K. Quint, A. Agaimy, P. Di Fazio Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC Virchows Arch 459 2011 129 139
15. J. Lu, G. Getz, E.A. Miska MicroRNA expression profiles classify human cancers Nature 435 2005 834 838 (Pubitemid 40839735)
16. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
17. E.A. Miska How microRNAs control cell division, differentiation and death Curr Opin Genet Dev 15 2005 563 568 (Pubitemid 41262414)
18. B. Skawran, D. Steinemann, T. Becker Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma Mod Pathol 21 2008 1479 1489
19. B. Skawran, D. Steinemann, A. Weigmann Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions Mod Pathol 21 2008 505 516 (Pubitemid 351589646)
20. D. Steinemann, B. Skawran, T. Becker Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization Clin Gastroenterol Hepatol 4 2006 1283 1291 (Pubitemid 44512219)
21. Y. Komatsu, K.Y. Tomizaki, M. Tsukamoto Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity Cancer Res 61 2001 4459 4466 (Pubitemid 32685775)
22. J. Vandesompele, K. De Preter, F. Pattyn Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 RESEARCH0034
23. J. Hellemans, G. Mortier, A. De Paepe qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data Genome Biol 8 2007 R19
24. S. Griffiths-Jones, R.J. Grocock, S. van Dongen miRBase: microRNA sequences, targets and gene nomenclature Nucleic Acids Res 34 2006 D140 D144
25. B.P. Lewis, C.B. Burge, D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20 (Pubitemid 40094598)
26. D.P. Bottaro, J.S. Rubin, D.L. Faletto Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product Science 251 1991 802 804 (Pubitemid 21926175)
27. K.A. Furge, Y.W. Zhang, G.F. Vande Woude Met receptor tyrosine kinase: enhanced signaling through adapter proteins Oncogene 19 2000 5582 5589
28. C. Birchmeier, W. Birchmeier, E. Gherardi Met, metastasis, motility and more Nat Rev Mol Cell Biol 4 2003 915 925 (Pubitemid 37493640)
29. C.F. Gao, G.F. Vande Woude HGF/SF-Met signaling in tumor progression Cell Res 15 2005 49 51 (Pubitemid 41653965)
30. S.A. Lee, S. Ladu, M. Evert Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis Hepatology 52 2010 506 517
31. S. Whittaker, R. Marais, A.X. Zhu The role of signaling pathways in the development and treatment of hepatocellular carcinoma Oncogene 29 2010 4989 5005
32. Y.X. Fang, J.L. Xue, Q. Shen MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma Hepatology 55 2012 1852 1862
33. J.A. Fahrner, S. Eguchi, J.G. Herman Dependence of histone modifications and gene expression on DNA hypermethylation in cancer Cancer Res 62 2002 7213 7218 (Pubitemid 36025241)
34. G. Kouraklis, S. Theocharis Histone deacetylase inhibitors and anticancer therapy Curr Med Chem Anticancer Agents 2 2002 477 484 (Pubitemid 34649886)
35. D.R. Walkinshaw, X.J. Yang Histone deacetylase inhibitors as novel anticancer therapeutics Curr Oncol 15 2008 237 243
36. M. Yoshida, A. Matsuyama, Y. Komatsu From discovery to the coming generation of histone deacetylase inhibitors Curr Med Chem 10 2003 2351 2358 (Pubitemid 37236392)
37. M. Dokmanovic, P.A. Marks Prospects: histone deacetylase inhibitors J Cell Biochem 96 2005 293 304 (Pubitemid 41437862)
38. Y. Zhao, J. Tan, L. Zhuang Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim Proc Natl Acad Sci U S A 102 2005 16090 16095 (Pubitemid 41552872)
39. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
40. L. Tuddenham, G. Wheeler, S. Ntounia-Fousara The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells FEBS Lett 580 2006 4214 4217 (Pubitemid 44037596)
41. U. Lehmann, B. Hasemeier, M. Christgen Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer J Pathol 214 2008 17 24
42. Y. Saito, G. Liang, G. Egger Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Cancer Cell 9 2006 435 443 (Pubitemid 43832188)
43. Y. Saito, J.M. Friedman, Y. Chihara Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells Biochem Biophys Res Commun 379 2009 726 731
44. G.K. Scott, M.D. Mattie, C.E. Berger Rapid alteration of microRNA levels by histone deacetylase inhibition Cancer Res 66 2006 1277 1281 (Pubitemid 43259904)
45. Y. Saito, P.A. Jones Epigenetic activation of tumor suppressor microRNAs in human cancer cells Cell Cycle 5 2006 2220 2222 (Pubitemid 44546557)
46. M. Lize, S. Pilarski, M. Dobbelstein E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis Cell Death Differ 17 2010 452 458
47. E.J. Noonan, R.F. Place, D. Pookot miR-449a targets HDAC-1 and induces growth arrest in prostate cancer Oncogene 28 2009 1714 1724
48. E.J. Noonan, R.F. Place, S. Basak miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells Oncotarget 1 2010 349 358
49. P. Olson, J. Lu, H. Zhang MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer Genes Dev 23 2009 2152 2165
50. X. Yang, M. Feng, X. Jiang miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A Genes Dev 23 2009 2388 2393
51. K. Leelawat, S. Leelawat, P. Tepaksorn Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met J Surg Res 136 2006 78 84 (Pubitemid 44634563)
52. P.C. Ma, M.S. Tretiakova, V. Nallasura Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion Br J Cancer 97 2007 368 377 (Pubitemid 47196754)